Bosia Marta Professore AssociatoMedicineMED/25

CURRENT POSITIONS

2015 ongoing: Researcher in Psychiatry, Vita-Salute San Raffaele University School of Medicine, Milan, Italy.

2009 ongoing: Psychiatrist, Department of Clinical Neurosciences, San Raffaele Scientific Institute, Milan, Italy.

 

EDUCATION AND TRAINING

2017: Habilitation as Associate Professor in Psychiatry according to the Italian National Scientific Habilitation Procedure (ASN 2016);

 

2015: PhD in Cognitive Neuroscience and Philosophy of Mind,Vita-Salute San Raffaele University, Milan -Institute for Advanced Study of Pavia;

2012: Master Degree in Medical Statistics and Statistical Methods in Epidemiology,  University of Milan;

2009: Board Certified Specialty in Psychiatry 70/70 cum laude; Vita-Salute San Raffaele University, Milan;

2006: Medical License, Italian Medical Council of Milan n.39940;

2005: Medical Degree, 110/110 cum laude, Vita-Salute San Raffaele University, Milan;

1998-1999: Semester course of studies, Nebraska State College, Lincoln, Nebraska (U.S).

 

MEMBERSHIPS

2006 ongoing: European College of Neuropsychopharmacology (ECNP).

2010 ongoing: Schizophrenia International Research Society (SIRS).

2014 ongoing: Associazione Riabilitatori Specialisti Ospedalità Privata (ARSOP).

 

RESEARCH INTERESTS

Research areas, focused on psychotic disorders, encompass: Clinical and Molecular Neuropsychology;  Clinical Psychopharmacology; Pharmacogenetics; Molecular Biology, Genetics and Epigenetics.

 

AWARDS

2012: Travel Award from the European College of Neuropsychopharmacology (ECNP), 25th Congress, Vienna, Austria.

2007: Young Scientist Travel Award from ECNP, Workshop on Neuropsychopharmacology for Young Scientists in Europe, Nice, France.

2006: Young Scientist Travel Award from ECNP, Workshop on Neuropsychopharmacology for Young Scientists in Europe, Nice, France.

RESEARCH GRANTS

2017-2020: “Understanding and Promoting Pragmatic Abilities across Lifespan and in Mental Illness”, Bando PRIN 2015, Italian Ministry of Education, Universities and Research. Role: Unit Coordinator.

TALKS AT CONFERENCES

Speaker at national and international conferences, including: Cognition in Schizophrenia: A Satellite Meeting of the Schizophrenia International Research Society (Florence 2010, 2012, 2014 and 2016); British Association for Behavioural & Cognitive Psychotherapies -39th Annual Conference (Guildford 2011); XII Annual Pharmacogenetics in Psychiatry Meeting (Miami 2013); Biolinguistic Investigations on the Language Faculty (Pavia 2015); 13th World Congress of Biological Psychiatry (Copenhagen 2017).

 

EDITORIAL ACTIVITY

Ad hoc referee for: Biological Psychiatry, Schizophrenia Research, Scientific Reports, Progress in Neuro Psychopharmacology & Biological Psychiatry, Psychiatry Research, Frontiers in Psychology, PLoS ONE, Journal of Affective Disorders, Neuroscience Letters, Brain and Behavior, Behavioural Brain Research, Asian Journal of Psychiatry, NeuroMolecular Medicine, Neuropsychiatric Disease and Treatment.

2016: member of the editorial board of SpringerPlus, Medicine section.

 

PUBLICATIONS

Author and co-author of over 60 publications starting from 2006, among which  papers on international peer reviewed journals  (36 and in 18  cases as first, senior or corresponding author), papers on national journals, book chapters and meeting abstracts.

Scopus H index= 11; Citations= 393 (Scopus).

 

 

• Buonocore M, Spangaro M, Bechi M, Baraldi MA, Cocchi F, Guglielmino C, Bianchi L, Mastromatteo A, Bosia M, Cavallaro R. Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5 years. Schizophr Res. 2017 May 22. pii: S0920-9964(17)30297-9. doi: 10.1016/j.schres.2017.05.022.

 

• Bosia M, Buonocore M, Bechi M, Spangaro M, Pigoni A, Croci M, Cocchi F, Guglielmino C, Bianchi L, Smeraldi E, Cavallaro R. Cognitive remediation and functional improvement in schizophrenia: Is it a matter of size? Eur Psychiatry. 2017 Feb;40:26-32. doi: 10.1016/j.eurpsy.2016.06.007.

 

• Bambini V, Arcara G, Bechi M, Buonocore M, Cavallaro R, Bosia M. The communicative impairment as a core feature of schizophrenia: Frequency of pragmatic deficit, cognitive substrates, and relation with quality of life. Compr Psychiatry. 2016 Nov;71:106-120. doi: 10.1016/j.comppsych.2016.08.012.

 

• Bechi M, Bosia M, Spangaro M, Buonocore M, Cocchi F, Pigoni A, Piantanida M, Guglielmino C, Bianchi L, Smeraldi E, Cavallaro R. Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. Psychol Med. 2015 Nov;45(15):3147-57. doi: 10.1017/S0033291715001129.

 

• Bosia M, Pigoni A, Cavallaro R. Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. Expert Opin Drug Discov. 2015 Feb;10(2):125-39. doi: 10.1517/17460441.2015.976552.

 

• Bosia M, Zanoletti A, Spangaro M, Buonocore M, Bechi M, Cocchi F, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E, Cavallaro R. Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment. Psychiatry Res. 2014 Jun 30;217(1-2):9-14. doi: 10.1016/j.psychres.2014.02.015.

 

• Llorca PM, Blanc O, Samalin L, Bosia M, Cavallaro R; EGOFORS Initiative. Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling. Eur Psychiatry. 2012 Aug;27(6):396-400. doi: 10.1016/j.eurpsy.2011.01.010.
• Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, Smeraldi E, Cavallaro R. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):81-5. doi: 10.1016/j.pnpbp.2009.10.001.

 

• Benedetti F, Bernasconi A, Bosia M, Cavallaro R, Dallaspezia S, Falini A, Poletti S, Radaelli D, Riccaboni R, Scotti G, Smeraldi E. Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia. Schizophr Res. 2009 Oct;114(1-3):154-60. doi: 10.1016/j.schres.2009.06.021.

 

• Bosia M, Bechi M, Marino E, Anselmetti S, Poletti S, Cocchi F, Smeraldi E, Cavallaro R. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia. Neurosci Lett. 2007 May 7;417(3):271-4.